Aethlon Medical, Inc. cash flow to debt ratio of -2.08B% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Aethlon Medical, Inc.'s free cash flow has decreased 91.58M% from $-7.65M last year to $-7.00T, signaling decreasing performance

Aethlon Medical, Inc.'s debt to equity ratio is 0.07, which means that the company's assets are healthy financed, signaling financial stability.

Aethlon Medical, Inc.'s debt has decreased relative to shareholder equity from 0.13 last year to 0.07 today, signaling strengthened financials

Aethlon Medical, Inc. has a net cash position, so leverage is healthy.

Aethlon Medical, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Aethlon Medical, Inc. has insufficient data to evaluate this check.

Aethlon Medical, Inc.'s short-term assets of $5.57M exceed its short-term liabilities of $1.45M

Aethlon Medical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Aethlon Medical, Inc.'s return on equity of -137.73%, is lower than 15.00%, indicating bad performance

Aethlon Medical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Aethlon Medical, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Aethlon Medical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Aethlon Medical, Inc. has negative free cash flow, indicating cash burn

Aethlon Medical, Inc.'s yearly earnings has increased -46.58% since last year from $-13.39M to $-7.15M, signaling increasing performance

Aethlon Medical, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -139.64% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Aethlon Medical, Inc.'s 3-year revenue CAGR of -100.00% is negative, indicating declining revenue over the past 3 years

Aethlon Medical, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Aethlon Medical, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Aethlon Medical, Inc. has insufficient data to evaluate this check.

Aethlon Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Aethlon Medical, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Aethlon Medical, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Aethlon Medical, Inc. has insufficient data to evaluate this check.

Aethlon Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Aethlon Medical, Inc. has a price-to-book ratio of 0.79x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Aethlon Medical, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue